Director, Contracting Analytics
Alnylam Pharmaceuticals | |
United States, Massachusetts, Cambridge | |
675 West Kendall Street (Show on map) | |
Oct 25, 2024 | |
This role is considered Virtual. SUMMARY OF POSITION: Reporting to the Senior Director, Strategic Pricing and Contracting, in the Market Access group, this role will support contracting initiatives, pricing, and financial analytics across the company portfolio of products. Additionally, this position will work closely with the Director, Strategic Pricing to review new contracting opportunities, develop strategies and present recommendations to senior management. This role will require strong cross-functional collaboration on all activities to ensure organizational alignment. This role leads a team responsible for the development and administration of contracts across multiple payer and channel segments.This person should be familiar with and able to discuss different segments of market access, discuss contracting strategies and tactics, understand the various types of managed care contracting and be able to determine the potential value of a contracting opportunity. ESSENTIAL FUNCTIONS:
MINIMUM REQUIREMENTS:
ORGANIZATIONAL RELATIONSHIPS/SCOPE: Key Customers Internal Customers: Senior Management, Market Access, Legal, Contract and Pricing, Brand Teams, Finance, Accounting, Government Pricing, Field Sales, Market Research, Business Development. External Customers: All Payers, including, as appropriate, Contracted Health Care Providers, GPOs, PBMs, MCOs, Employers, and Third-Party Data Aggregator. About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. > |